Monday, December 23, 2024
HomeTagsPhase 2b Trial

Phase 2b Trial

NeuroSense Receives Regulatory Approval to Commence Patient Enrollment in Italy

NeuroSense Therapeutics Ltd., a company developing treatments for severe neurodegenerative diseases, announced it has received approval from the Italian Medicines Agency (AIFA) to commence...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics